The IGF pathway is activated in insulinomas but downregulated in metastatic disease.

Henfling, Mieke; Perren, Aurel; Schmitt, Anja Maria; Saddig, Christiane M; Starke, Achim A; Riedl, Robert G; Versleijen-Jonkers, Yvonne M H; Sprij-Mooij, Diane M; Ramaekers, Frans C S; Hofland, Leo; Speel, Ernst-Jan M (2018). The IGF pathway is activated in insulinomas but downregulated in metastatic disease. (In Press). Endocrine-related cancer BioScientifica Ltd. 10.1530/ERC-18-0222

Preview

Text Aurel2.pdf - Accepted Version Available under License Publisher holds Copyright. Download (1MB) | Preview

Clinical and molecular studies have implicated epidermal growth factor receptor (EGFR), insulin-like growth factor (IGF) and target of rapamycin (mTOR) signaling pathways in the regulation of pancreatic neuroendocrine tumor (PanNET) growth. Interpretation and comparison of these studies is complex due to clinical and molecular tumor heterogeneity. We therefore focused in this study on insulinomas, which we examined for mRNA and protein expression of EGFR, IGF and mTOR signaling pathway components by quantitative real-time PCR (n=48) and immunohistochemistry (n=86). Findings were compared with normal pancreatic islets and correlated with histopathological data and clinical outcome. Insulinomas showed low EGFR and high IGF2 expression. IGFBP2, IGFBP3 and IGFBP6 mRNA levels were 2-4 folds higher than in islets. High protein expression of IGF2, IGF1R and INSR (in 51-92% of the tumors) and low to moderate expression of mTORC1 pathway proteins p-PS6k and p-4EBP1 (7-28% of the tumors) were observed. Correlations were found between 1) ERK1 mRNA expression and that of numerous IGF pathway genes, 2) p-ERK and IGF1R protein expression and 3) decrease of IGF pathway components and both metastatic disease and shorter 10 years disease free survival. In conclusion, our observations suggest that high expression of IGF signaling pathway components is a hallmark of insulinomas, but does not necessarily lead to increased mTOR signaling. Reduced expression of IGF pathway components may be an adverse prognostic factor in insulinomas.

Interest & Impact

Downloads

190 since deposited on 30 Aug 2018
17 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item